Redefining multiple sclerosis: 2024 McDonald diagnostic criteria

Hazal Ceren Manazoğlu, Murat Kürtüncü

DOI: 10.55697/tnd.2025.500

Issue: 2025, Volume 31 - Issue 3
34782 15134

Association of lifestyle, psychological, and biological risk factors with multiple sclerosis: A case-control study

Rahim Aliyev, Aytan Mammadbayli, Rana Shiraliyeva

DOI: 10.55697/tnd.2025.494

Issue: 2025, Volume 31 - Issue 3
2750 2264

Long-term cladribine experience in relapsing-remitting multiple sclerosis

Ömer Faruk Turan, Furkan Sarıdaş, Emine Rabia Koç

DOI: 10.55697/tnd.2025.293

Issue: 2025, Volume 31 - Issue 3
2132 1954

Association between urinary symptoms, quality of life, and pelvic floor function in females diagnosed with multiple sclerosis

Seda Kılıç, Ayşe Neriman Yılmaz, Murat Terzi

DOI: 10.55697/tnd.2025.323

Issue: 2025, Volume 31 - Issue 4
1424 1346

Relationship between education status and cerebrovascular disease awareness in patients with ischemic stroke

Gizem Gürsoy, Havva Tuğba Çelik

DOI: 10.55697/tnd.2025.431

Issue: 2025, Volume 31 - Issue 4
1438 1129

Audiovestibular findings according to the subtypes of multiple sclerosis

Fatmanur Uysal, Selim S. Erbek, Alper Köycü, Osman Halit Çam, Meliha Güleryüz

DOI: 10.55697/tnd.2025.442

Issue: 2025, Volume 31 - Issue 4
1351 1573

Development of restless legs syndrome severity prediction models for people with multiple sclerosis using machine learning

Ergi Kaya, Murat Emeç, Asiye Tuba Özdoğar, Ela Simay Zengin, Hilal Karakaş, Seda Daştan, Cavid Baba, Mehmet Hilal Özcanhan, Serkan Özakbaş

DOI: 10.55697/tnd.2025.511

Issue: 2025, Volume 31 - Issue 4
1598 1516

Efficacy and safety of intravenous thrombolytic therapy in acute ischemic stroke: Predictors of good prognosis and outcomes of the elderly population

Burak Gürel, Vedat Ali Yürekli

DOI: 10.55697/tnd.2026.578

Issue: 2026, Volume 32 - Issue 1
1096 999

Clinical prediction model for early neurological deterioration in patients with mild nondisabling ischemic stroke within 4.5 hours of onset

Lin Lu, Hongying Ma

DOI: 10.55697/tnd.2026.575

Issue: 2026, Volume 32 - Issue 1
1951 1060

Nationwide prescription big data: An evaluation of injectable, oral, and monoclonal antibody disease-modifying therapies in multiple sclerosis

Esra Taşkıran, Bilgin Öztürk, Naim Ata, Şuayip Birinci

DOI: 10.55697/tnd.2026.622

Issue: 2026, Volume 32 - Issue 1
1297 836

Rescue mechanical thrombectomy for large vessel occlusion during endovascular treatment of aneurysmal subarachnoid hemorrhage: A case report

Martin Vasilev, Vladina Dimitrova-Kirilova, Nora Ivanova, Tihomir Drenski, Georgi Todorov, Chavdar Bachvarov, Mihael Tsalta-Mladenov

DOI: 10.55697/tnd.2026.568

Issue: 2026, Volume 32 - Issue 1
1050 870

Six-month prognosis of acute ischemic stroke in patients with cancer: A prospective study

Hasan Hüseyin Kozak, Murat Araz, Ayşenur İnce, Ahmet Buğrul

DOI: 10.55697/tnd.2026.627

Issue: 2026, Volume 32 - Issue 2
1523 591

Determinants of stroke recurrence in a nationwide multicenter cohort

Nazlı Gamze Bülbül, Bilge Piri Çınar, Refik Kunt, Burcu Yüksel, Halil Güllüoğlu, İdris Saylır, Sibel Çeliker Uslu, Eylem Özaydın Göksu, Baykal Yıldız, Didem Öz, Ahmet Onur Keskin, Osman Korucu, Çetin Kürşad Akpınar, Volkan Solmaz, Meliha Türksever, Fatma Zehra Altunç, Zeynep Elmas, Mustafa Ekici, Murat Mert Atmaca, Sibel Karşıdağ, Mehmet Fatih Özdağ

DOI: 10.55697/tnd.2026.613

Issue: 2026, Volume 32 - Issue 2
1731 687

Recorded diagnosis-based incidence and point prevalence of multiple sclerosis in Azerbaijan between 2013 and 2022: Estimates from a national referral center registry

Rahim Aliyev, Ayten Mammadbayli, Rana Shiraliyeva

DOI: 10.55697/tnd.2026.749

Issue: 2026, Volume 32 - Issue 3
165 103